Immunotherapy against several tumors, such as lung cancer, including NSCLC

  • US 10,316,063 B1
  • Filed: 02/22/2019
  • Issued: 06/11/2019
  • Est. Priority Date: 08/05/2013
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save
    ×



    ×

    Thank you for your feedback

    ×
    ×